Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

Clinical trial NCT06784947 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06784947
Sponsor: University of Colorado, Denver
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Microsatellite Stable (MSS) Colorectal Cancer (CRC)Metastatic Colorectal Cancer (CRC)Colorectal Cancer Stage IV

Start date: 2025-03-25
Primary completion: 2025-09-18
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.